Shares of Inspire Medical Systems INSP were flat in after-market trading after the company reported Q2 results.
Quarterly Results
Earnings per share were down 175.00% year over year to ($0.88), which beat the estimate of ($1.10).
Revenue of $12,183,000 declined by 32.44% from the same period last year, which beat the estimate of $7,850,000.
Outlook
Earnings guidance hasn't been issued by the company for now.
Revenue guidance hasn't been issued by the company for now.
How To Listen To The Conference Call
Date: Aug 04, 2020
Time: 05:00 PM
ET Webcast URL: http://public.viavid.com/player/index.php?id=140429
Price Action
Company's 52-week high was at $105.53
Company's 52-week low was at $40.53
Price action over last quarter: Up 46.22%
Company Overview
Inspire Medical Systems Inc operates as a medical technology company. It focuses on the development and commercialization of minimally invasive solutions for patients with obstructive sleep apnea (OSA). It offers Inspire system, a neurostimulation technology that provides a safe and effective treatment for moderate to severe obstructive sleep apnea. The firm has operating footprints in the United States and Europe wherein, it generates a majority of its revenue from the United States.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Date | ticker | name | Actual EPS | EPS Surprise | Actual Rev | Rev Surprise |
|---|
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
